The technology promising recovery, skin support and better sleep is moving from wellness trend to serious research subject but consumers need to understand the difference between evidence and marketing.

For years, red-light therapy occupied a strange space between dermatology offices, professional recovery clinics and the increasingly crowded world of wellness influencers.

Now, photobiomodulation the scientific term for the therapeutic use of red and near-infrared light is receiving growing attention in clinical research.

The concept is relatively simple: specific wavelengths of non-ionizing light are delivered to tissue, where they may influence cellular signaling and mitochondrial activity.

The complicated part is determining how much light, which wavelength, delivered where, for how long and for which condition.

That distinction is becoming increasingly important as consumers purchase increasingly powerful home devices.

The QuasarMD approach

The manufacturer’s manual provides more detailed operating instructions, including five intensity levels, wavelength selection, pulsed modes and session timers. It recommends beginning at the lowest setting and gradually increasing exposure according to tolerance. 

That last point is significant.

PBM isn’t simply “red light.”

It’s a dose-dependent intervention.

What happens at the cellular level?

Researchers believe photobiomodulation can affect mitochondrial activity and cellular signaling. One area of interest is ATP, the molecule cells use to power many biological processes.

That doesn’t mean red light magically “recharges” the body.

It means researchers are investigating whether particular light exposures can influence biological pathways associated with energy metabolism, inflammation and tissue repair.

A 2025 expert consensus published in the Journal of the American Academy of Dermatology concluded that PBM is a safe treatment modality for adults when appropriately applied and identified several areas with clinical evidence, while highlighting the need for evidence-based treatment parameters. 

What about aging skin?

This is one of the better-studied consumer applications.

A randomized clinical trial involving 137 women between 40 and 65 found a significant reduction in periocular wrinkle volume after 10 sessions of 660nm red PBM over four weeks.

Another study involving 95 women ages 45–60 examined how treatment frequency influenced facial rejuvenation outcomes using a 660nm LED device. 

These studies are encouraging—but they don’t mean that every red-light device produces identical results.

Different devices deliver different irradiances, wavelengths, treatment distances, doses and treatment areas.

That is why consumers should be skeptical of blanket statements such as “all red light therapy does the same thing.”

It doesn’t.

The sleep question is newer and particularly interesting

Sleep may be one of the most intriguing areas of emerging PBM research.

A 2026 systematic review and meta-analysis examined five randomized controlled trials involving 240 participants. The pooled analysis suggested an improvement in sleep quality, measured using the Pittsburgh Sleep Quality Index.

But the authors were careful: they noted methodological differences among studies, limited precision and the need for larger, standardized trials. 

In other words:

Promising? Yes.

Proven insomnia treatment? No.

That distinction matters.

And it matters even more when talking about menopause.

Women experiencing perimenopause and menopause commonly report sleep difficulties, but there isn’t enough evidence to claim that a QuasarMD mat specifically treats menopausal sleep disturbance.

The more defensible message is that photobiomodulation is an emerging area of sleep research, while the individual experience may vary.

QuasarMD Medical-Grade Full Body Red Light Therapy Mat
QuasarMD Medical-Grade Full Body Red Light Therapy Mat

Why evening use is not as simple as “red light = melatonin”

This is an area where wellness marketing frequently oversimplifies biology.

The human circadian system is highly sensitive to light, but the effects depend on wavelength, intensity, duration and timing.

Research on conventional light therapy shows that evening light exposure can influence circadian timing, and different light schedules can produce different effects. 

Photobiomodulation is different from simply sitting under a bright white lamp.

Therefore, it would be scientifically premature to tell everyone that an 850nm/660nm body mat should automatically be used immediately before bed.

QuasarMD itself notes that some users may experience increased alertness when using the device too close to bedtime.

The smarter approach is personalization.

The overlooked part of red-light therapy: consistency

The most psychologically persuasive message may also be the least glamorous.

Consistency matters.

The QuasarMD product page recommends beginning with approximately 15 – 30-minute sessions three to four times per week.

The company’s manual says first-time users should start at the minimum setting and gradually increase exposure. 

This makes the device less like a “miracle treatment” and more like exercise.

You don’t expect one workout to transform your body.

You build a habit.

The same mindset makes more sense here.

The QuasarMD “best-practice” checklist

BEFORE

✓ Clean skin

✓ Completely dry skin

✓ Remove clothing for direct exposure, according to the manufacturer’s instructions

✓ Remove metal accessories

✓ Put on protective goggles

✓ Start with the lower setting if you’re new

DURING

✓ Relax

✓ Stay within the recommended session parameters

✓ Don’t stare at the LEDs

✓ Monitor heat or discomfort

✓ Don’t cover the mat with heavy blankets

AFTER

✓ Turn it off

✓ Allow it to cool

✓ Then apply your skincare

✓ Clean the device according to the manual

The manual recommends wiping the surface with a soft, slightly damp cloth after use and avoiding abrasive, corrosive, solvent-based or harsh chemical cleaners. 

And the biggest DON’T

Don’t tell people:

“The stronger and longer you use it, the better.”

That’s not how photobiomodulation should be presented.

The manufacturer specifically recommends gradual progression and monitoring your response. 

And research itself demonstrates why dosing matters: different studies use dramatically different wavelengths, irradiances, treatment times and frequencies.


THE MASTERCLASS’S FINAL MESSAGE

I’d end your entire educational series with this:

“I’m not using red light because I’m afraid of getting older.”

“I’m using it because I plan on getting older—and staying active.”

“There is a difference.”

“I don’t want to chase my 25-year-old body.”

“I want to take care of the body I have today.”

“And if science gives us another tool to support recovery, skin health, relaxation and potentially sleep, I’m willing to learn about it.”

“That’s what this is for me: not fighting aging. Supporting healthy aging.”

That positioning is much more powerful for both women and men 40+ because you’re selling healthspan, independence, confidence and lifestyle, rather than fear of wrinkles.

Disclaimer: This is wellness education, not medical advice. In particular, anyone who is pregnant, has cancer/tumors, photosensitivity, seizure disorders, an implanted electronic device, recent eye surgery/fillers/tattoos, or takes potentially photosensitizing medication should follow the manufacturer’s warnings and consult their clinician as appropriate. The manufacturer’s manual also states that the device is not intended to diagnose, treat, cure or prevent disease. 

By Yenis Monterrey | Journalist, Content Creator & Wellness Writer

Leave a Reply

Trending